ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,796.00
0.34%
S&P ASX All Technology
3,092.40
0.70%
Brent Oil
84.39
0.00%
US Dollar vs AUD
1.50433
0.50%
Bitcoin
64,142.50
-0.16%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Exagen Inc (XGN) Share Price

Exagen Inc

Exagen Inc (XGN)

NASDAQ
1.96
0.00
(0.00%)
Closed 24 June 6:00AM
Delayed by 15 minutes
1.9693
0.0093
(0.47%)
After Hours: 9:59AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.96
Bid
1.79
Offer
2.99
Volume
36,492
1.8695 Day's Range 1.97
1.3003 52 Week Range 3.27
Market Cap
34.226M
Previous Close
1.96
Open
1.95
Last Trade
6032
@
1.9584
(priorref)
Last Trade Time
Financial Volume
US$ 70,369
VWAP
1.9283
Average Volume (3m)
39,590
Shares Outstanding
17,373,482
Dividend Yield
-
PE Ratio
-1.44
Earnings Per Share (EPS)
-1.36
Revenue
52.55M
Net Profit
-23.69M

About Exagen Inc

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differentia... Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.exagen.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Exagen Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker XGN. The last closing price for Exagen was US$1.96. Over the last year, Exagen shares have traded in a share price range of US$ 1.3003 to US$ 3.27.

Exagen currently has 17,373,482 shares in issue. The market capitalisation of Exagen is US$34.23 million. Exagen has a price to earnings ratio (PE ratio) of -1.44.

XGN Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

13 June 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 June 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

13 June 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 June 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

17 May 2024
Edgar (US Regulatory)

Healthcare Shares Soar Following Major Price Target Increase

Just one session following the company releasing strong Q1 2024 earnings, a California-based healthcare company is finding tremendous success on Tuesday. This comes as no real To read the full...

15 May 2024
AllPennyStocks.com

Form S-8 - Securities to be offered to employees in employee benefit plans

13 May 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 May 2024
Edgar (US Regulatory)

Form 8-K - Current report

13 May 2024
Edgar (US Regulatory)

Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

CARLSBAD, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31...

13 May 2024
GlobeNewswire Inc.
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10.010.5128205128211.952.061.86313821.97428462CS
4-0.03-1.507537688441.992.11.86266211.97035583CS
120.3420.9876543211.622.11.3003395901.74519255CS
260.179.497206703911.792.41.3003444391.8490329CS
52-1.23-38.55799373043.193.271.3003353471.90399295CS
156-13.93-87.665198237915.8917.391.3003430005.91185593CS
260-14.84-88.333333333316.829.8581.30034594510.52516544CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ME1OEMelodiol Global Health Ltd
AUD 0.006
(100.00%)
34
K2FK2fly Limited
AUD 0.1825
(82.50%)
2.49M
PRXProdigy Gold NL
AUD 0.003
(50.00%)
100.11k
ARVOCArtemis Resources Limited
AUD 0.003
(50.00%)
1.05M
MTBMount Burgess Mining Nl
AUD 0.0015
(50.00%)
5.38k
BNROBulletin Resources Limited
AUD 0.001
(-66.67%)
100k
FRSOAForrestania Resources Ltd
AUD 0.006
(-57.14%)
26k
GGEOAGrand Gulf Energy Limited
AUD 0.001
(-50.00%)
2.18M
D2OOADuxton Water Limited
AUD 0.021
(-47.50%)
4.5k
CT1Constellation Technologies Limited
AUD 0.002
(-33.33%)
50.02k
REDRed 5 Limited
AUD 0.4175
(3.09%)
135.31M
BGLBellevue Gold Limited
AUD 1.835
(-1.34%)
81.32M
NICNickel Industries Ltd
AUD 0.825
(-3.23%)
62.62M
S32South32 Limited
AUD 3.74
(1.77%)
56.22M
CXOCore Lithium Ltd
AUD 0.0855
(-6.04%)
56.06M

Discussion

View Full Feed
Vexari Vexari 3 minutes ago
Jack guy on pit crew

Is the quarterback

Hydration is fuel
Zardiw Zardiw 3 minutes ago
$BIOL has great tech.........fwiw............

Z
BIOL
DewDiligence DewDiligence 3 minutes ago
Listen starting at about 50:00 panelist comment re regulator risk. Can you post the link for this webcast? TIA
littlejohn littlejohn 3 minutes ago
snow jobs in summer 2024, EV to Ai...

https://stocktwits.com/talkin_stocks/message/577399903

NVDA CEO got about 60% more on

recent share sales than he would

have gotten only 30 days ago...

https://stocktwits.com/Mrdrifter
NVDA
gedi8 gedi8 3 minutes ago
TD I suspect he is
RXMD
Ayock Ayock 3 minutes ago
Not invited...

https://scontent-sea1-1.xx.fbcdn.net/v/t39.30808-6/442414848_122116591688282558_9068724328540552543_n.jpg?_nc_cat=108&ccb=1-7&_nc_sid=5f2048&_nc_ohc=OOaAJfDoH88Q7kNvgHF0Ctq&_nc_ht=scontent-sea1-1.xx&oh=00_AYCGc35rQoGbj72a9M97ieRmNcL0qf2g9KgxBaOdoSyyHA&oe=667E4BFC
surfkast surfkast 3 minutes ago
OMG! What a bunch of BS Hopium! LOLOLOL
SRNW
cjstocksup cjstocksup 4 minutes ago
https://x.com/RyanAFournier/status/1804523672431968565
ilovetech ilovetech 5 minutes ago
I hear you!
Plus I despise flying anymore.
NWBO
doc2016 doc2016 5 minutes ago
uspatent 9405736

i hope it's a patent for setting up the parallel computing gpu and cpus and asics environments for cuda operations...
dukeb dukeb 5 minutes ago
All it takes is one.

Are there a lot of careening buses in Christchurch?
DewDiligence DewDiligence 5 minutes ago
Excerpt from the NYT story on PBMs: The P.B.M.s…are driving independent drugstores out of business by not paying them enough to cover their costs. Small pharmacies have little choice but to accept these lowball rates because the largest P.B.M.s control an overwhelming majority of prescriptions. The
CVS
DewDiligence DewDiligence 6 minutes ago
NYT cover story on PBMs—>old hat for readers of this board; check out the date of the message this post is replying to!

https://www.nytimes.com/2024/06/21/business/prescription-drug-costs-pbm.html
cjstocksup cjstocksup 6 minutes ago
https://x.com/catturd2/status/1804401271161401537
cjstocksup cjstocksup 6 minutes ago
https://x.com/libsoftiktok/status/1804247426762477950
J-fire J-fire 7 minutes ago
My average share price for NKLA is ~$2.8. It is my bad that I didn't do anything to trade it when I still can. With a 1:30 RS, I don't know how to make money out of this scamming dilution. I even don't believe that the shareholders approved the split.
NKLA
cjstocksup cjstocksup 7 minutes ago
https://x.com/GuntherEagleman/status/1804657403926925543
goldslacker2023 goldslacker2023 8 minutes ago
Some will do fake news, some might use extra profiles to post comments, and etcetera. Not my style.
GNCP
kayak_wench kayak_wench 8 minutes ago
Thanks, good to get facts as I didn't have time today to figure it out for myself.
ELTP
newmedman newmedman 8 minutes ago
pbs.twimg.com/media/GQxZ-jUX0AA739g?format=jpg&name=medium
Foogie88 Foogie88 8 minutes ago
“ My point is that what's really needed is some worldwide changes, not zeroing in on the CEO and others in our tiny company.”

Im zeroing in on our CEO of our tiny company, b/c that’s one place I have a significant amount of my $$ in !
NWBO
cjstocksup cjstocksup 9 minutes ago
And here is,

the greatest domestic threat,

CIA John Brennan fighting a court subpoena for Maricopa County to turn over routers and router images to auditors,

Arizona Senate, Audit Director: Ken Bennett “It’s very concerning” that Dominion has passwords,
sab63090 sab63090 10 minutes ago
yes, that's how I read it, too!

Maybe it was a quick 12 min presentation with them remaining much longer for questions for anyone approaching their kiosk or whatever the set up is there.
AVXL
BDEZ BDEZ 10 minutes ago
Could not make the rally last week, too busy....heard it was a good turnout.

Your Recent History

NASDAQ
XGN
Exagen
TG
A19NTA
CNH Industrial Finance E...
NASDAQI
OMXHBPI
OMX Helsinki Benchmark PI
BIT
UC5CEZ
Unicredit Bank
EU
CADEK
Caisse dAmortissement de...
USOTC
BVNKF
Bavarian Nordic AS (PK)
LSE
0QLU
Basler Kantonalbank
BOV
WHRL4F
WHIRLPOOL PN
NASDAQI
CX601010PI
OMX Copenhagen Oil, Gas ...
BOV
VIVR12
VIVER
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved